seed
Stage
2020
Founded
2
Investors
About
Orikine Bio develops precision-engineered, bi-specific cytokine therapies using its Foldikine™ platform to treat severe autoimmune and inflammatory diseases by reprogramming immune signaling.
Explore Orikine Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.